Drugs that contain Glucagon
1. Drug name - BAQSIMI
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10213487 | ELI LILLY AND CO | Nasal powder formulation for treatment of hypoglycemia |
Feb, 2036
(13 years from now) | |
| US10894133 | ELI LILLY AND CO | Device for dispensing a fluid product |
Jan, 2038
(15 years from now) | |
| US10765602 | ELI LILLY AND CO | Medication delivery systems and methods |
Sep, 2039
(16 years from now) | |
Treatment: Treatment of severe hypoglycemia in patients with diabetes
Dosage: POWDER;NASAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 3MG | POWDER;NASAL | Prescription |
2. Drug name - GVOKE HYPOPEN
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9649364 | XERIS | Methods for producing stable therapeutic formulations in aprotic polar solvents |
Apr, 2036
(13 years from now) | |
Treatment: Treatment of severe hypoglycemia
Dosage: SOLUTION;SUBCUTANEOUS
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 0.5MG/0.1ML (0.5MG/0.1ML) | SOLUTION;SUBCUTANEOUS | Prescription |
| 1MG/0.2ML (1MG/0.2ML) | SOLUTION;SUBCUTANEOUS | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.